Notable Analyst Rating Changes 12/24: PLD, SLF, SUPX Upgraded; AMAG, CCJ, KV Downgraded
More News related to AMAG
- AMAG Pharmaceuticals, Inc. to Participate in the Lazard Capital Markets 6th Annual Healthcare Conference
- Baird Reiterates an 'Outperform' on AMAG Pharmaceuticals (AMAG); Incrementally Positive on CMS News
- AMAG Pharma (AMAG) Posts Q3 Loss of $1.29
- AMAG Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2009
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
More News related to CCJ
- Notable Analyst Rating Changes 11/23: SBUX, DE, SEED, NDAQ Upgraded; AGU, TRA, CIEN, FL Downgraded
- Raymond James Initiates Coverage on Cameco (CCJ) with a Market Perform
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Cameco's (CCJ) CEO, Grandey, Says Co. Considering Acquisitions, Calls Paladin an 'Interesting' Asset
- Cameco (CCJ) Posts Q3 adj.-EPS of $0.26, Misses Street Estimates
More News related to GOOG
- Google (GOOG) Acquires San Mateo Startup Teracent
- Microsoft and Murdoch's News Corp Discussing Google Workaround
- Google (GOOG) Gives a Sneak Peak of Chrome OS
- Another Analyst Boosts Google (GOOG) Price Target to $700, This Time UBS
- Google to Offer Live Webcast of Google Chrome OS Update
More News related to Special Reports
- Transcept Pharma (TSPT) to Meet with U.S. FDA To Discuss NDA Response Letter for Intermezzo
- DARA BioSciences (DARA) Says Clinical Trial on KRN5500 Achieved Its Primary Endpoint
- Nymox Pharmaceutical (NYMX) Announces Positive Clinical Data on BPH Drug NX-1207
- ARCA Biopharma (ABIO) Annouces Gencaro OK'd by U.S. FDA for Fast Track Program
- Ception and Cephalon (CEPH) Report Initial Results from Phase IIb/III Trial for CINQUIL(TM)
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Wachovia and Deutsche Bank upgrade ProLogis (NYSE: PLD) to Outperform and Buy, respectively.
CIBC upgrades Sun Life (NYSE: SLF) from Sector Perform to Sector Outperform.
Lazard Capital Markets upgrades Supertex (Nasdaq: SUPX) from Hold to Buy.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Merrill Lynch downgrades AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) from Neutral to Underperform and cuts its price target from $30 to $27.
Friedman Billings downgrades Cameco Corp. (NYSE: CCJ) from Outperform to Market Perform with a $13 price target.
Gabelli & Co downgrades KV Pharmaceuticals (NYSE: KV.A) from Buy to Hold. Price target $2.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Wunderlich Securities initiates coverage on Legacy Reserves (Nasdaq: LGCY) with a Buy. Price target $11.
Signal Hill initiates coverage on Yahoo! (Nasdaq: YHOO) with a Hold rating.
Signal Hill initiates coverage on Google (Nasdaq: GOOG) with a Hold rating.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-0.65
+0.09Related Entities
- Deutsche Bank
- Merrill Lynch
- CIBC
- Wachovia
- Friedman, Billings, Ramsey
- Lazard
- Gabelli & Company
- Notable Analyst Rating Changes
- Wunderlich Securities
- Signal Hill
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
